Medicare And CAR-Ts: Breyanzi Denied Add-On Payments But Tecartus, Abecma Approved

 
• By Cathy Kelly

CMS shows willingness to continue approving new technology add-on payments for CAR-T treatments despite suggestions they are no longer needed.

Add-On Payments Aim To Close Gap Between Base Medicare Reimbursement And Hospital Costs

More from Market Access

More from Pink Sheet